US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Sable Offshore Corp.

5.10

+0.03000.59%

Post-market: 5.140.0400+0.78%19:59 EDT

Volume:10.93M

Turnover:55.96M

Market Cap:979.20M

PE:-1.51

High:5.44

Open:5.08

Low:4.94

Close:5.07

52wk High:29.00

52wk Low:2.88

Shares:192.00M

Float Shares:166.78M

Volume Ratio:0.76

T/O Rate:6.55%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.3799

EPS(LYR):-4.1777

ROE:-103.21%

ROA:-14.02%

PB:2.48

PE(LYR):-1.22

Loading ...

Overview Company News Filings

Rezolute Announces Four Presentations at the Upcoming Annual Meeting of the Endocrine Society

Jefferies Remains a Buy on Sable Offshore (SOC)

Gerdes Energy Research downgrades Sable Offshore (SOC) to a Hold

U.S. RESEARCH ROUNDUP-Edgewise Therapeutics, IBM, Rubrik

Sable Offshore Corp : Gerdes Energy Research Cuts to Neutral From Buy; Cuts Target Price by $4 to $13

THOMSON REUTERS

Trump secretaries to visit Sable Offshore, Politico reports

Sable Offshore price target lowered to $22 from $24 at Roth Capital

Sable Offshore says Platform Hondo expected to come online in Q3

UCB and Biogen Announce Publication in The Lancet of Positive Dapirolizumab Pegol (DZP) Phase 3 Study Results in Systemic Lupus Erythematosus

District court denies California parks department bid to block Sable Offshore pipeline

Systemic immune activation with eftilagimod alfa associated with statistically significant increased overall survival in late-stage cancer patients

Sable Offshore Corp put volume heavy and directionally bearish

Genmab to Highlight Advances Across Its Oncology Portfolio at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and the European Hematology Association (EHA) 2026 Congress

How Investors Are Reacting To Sable Offshore (SOC) Deeper Losses And High‑Risk Offshore Restart Strategy

Simply Wall St.

GRI Bio Reports First Quarter 2026 Financial Results, New Data Reinforcing Differentiated Profile of GRI-0621 in Idiopathic Pulmonary Fibrosis and Highlights Continued Advancement of Differentiated Immune-Modulating Pipeline

MEDIPOST's CARTISTEM® Meets All Primary and Secondary Endpoints in Japan Phase 3 Trial and Demonstrates Statistically Significant Efficacy Gains Versus Active Control

Press Release: Sionna Therapeutics Reports First Quarter 2026 Financial Results

Emerging Growth Status at Sable Offshore Corp. Raises Transparency and Valuation Concerns

Press Release: IN8bio Reports First Quarter 2026 Financial Results and Recent Business Highlights

Sable Offshore (SOC) Receives a Rating Update from a Top Analyst

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/SOC/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SOC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SOC\",,,,,undefined,":{"symbol":"SOC","market":"US","secType":"STK","nameCN":"Sable Offshore Corp.","latestPrice":5.1,"timestamp":1787342400000,"preClose":5.07,"halted":0,"volume":10931065,"hourTrading":{"tag":"盘后","latestPrice":5.14,"preClose":5.1,"latestTime":"19:59 EDT","volume":267075,"amount":1360260.5933,"timestamp":1787356774845,"change":0.04,"changeRate":0.007843,"amplitude":0.035216},"delay":0,"changeRate":0.005917159763313483,"floatShares":166783417,"shares":192000000,"eps":-3.379911,"marketStatus":"Market Closed","change":0.03,"latestTime":"08-21 16:00:00 EDT","open":5.08,"high":5.435,"low":4.94,"amount":55964544.1205825,"amplitude":0.097633,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.379911,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"exchange":"NYSE","adjPreClose":5.07,"preHourTrading":{"tag":"盘前","latestPrice":5.05,"preClose":5.07,"latestTime":"09:25 EDT","volume":9321,"amount":46672.011465300006,"timestamp":1787318741193,"change":-0.02,"changeRate":-0.003945,"amplitude":0.035286},"postHourTrading":{"tag":"盘后","latestPrice":5.14,"preClose":5.1,"latestTime":"19:59 EDT","volume":267075,"amount":1360260.5933,"timestamp":1787356774845,"change":0.04,"changeRate":0.007843,"amplitude":0.035216},"volumeRatio":0.7620600107308088,"impliedVol":1.1228,"impliedVolPercentile":0.0837},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SOC\",,,,,undefined,":{"symbol":"SOC","floatShares":166783417,"roa":"-14.02%","roe":"-103.21%","lyrEps":-4.177665,"volumeRatio":0.7620600107308088,"shares":192000000,"dividePrice":0,"high":5.435,"amplitude":0.097633,"preClose":5.07,"low":4.94,"week52Low":2.88,"pbRate":"2.48","psRate":"7.08","week52High":29,"institutionHeld":0,"latestPrice":5.1,"eps":-3.379911,"divideRate":0,"volume":10931065,"delay":0,"ttmEps":-3.379911,"open":5.08,"prevYearClose":9.02,"prevWeekClose":4.15,"prevMonthClose":5.29,"prevQuarterClose":3.08,"fiveDayClose":4.15,"twentyDayClose":4.71,"sixtyDayClose":13.13},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SOC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-10","symbol":"SOC","fiscalQuarterEnding":"2026/06","expectedEps":0.21,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786334400000,"reportTimeType":"post","actualEps":0.05},{"market":"US","date":"2026-05-06","symbol":"SOC","fiscalQuarterEnding":"2026/03","expectedEps":-0.64,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778040000000,"reportTimeType":"post","actualEps":-1.37},{"market":"US","date":"2026-02-27","symbol":"SOC","fiscalQuarterEnding":"2025/12","expectedEps":-0.59,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1772168400000,"reportTimeType":"post","actualEps":-0.39},{"market":"US","date":"2025-11-13","symbol":"SOC","fiscalQuarterEnding":"2025/09","expectedEps":-0.9,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-1.11},{"market":"US","date":"2025-08-12","symbol":"SOC","fiscalQuarterEnding":"2025/06","expectedEps":-0.66,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"pre","actualEps":-1.1}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SOC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SOC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.5,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":4,"updateTime":1772769600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SOC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SOC","date":"2026-08-21","current":-1.508915,"percent":0.895082,"low":-49.514744,"twenty":-5.313857,"median":-4.13367,"eighty":-2.944188,"high":-0.945554,"avg":-6.808098,"sd":9.71909,"marketCap":972778730},"quantilePoints":[{"date":"2024-02-16","current":-10.965511,"twenty":-10.965511,"median":-10.965511,"eighty":-10.965511,"marketCap":164955978},{"date":"2024-02-23","current":-47.994905,"twenty":-48.050899,"median":-47.994905,"eighty":-40.589026,"marketCap":721995228},{"date":"2024-03-01","current":-48.874812,"twenty":-48.810818,"median":-47.994905,"eighty":-47.810925,"marketCap":735231807},{"date":"2024-03-08","current":-48.51485,"twenty":-48.842815,"median":-48.51485,"eighty":-47.970908,"marketCap":729816842},{"date":"2024-03-15","current":-46.995011,"twenty":-48.834816,"median":-48.13489,"eighty":-47.810925,"marketCap":706953660},{"date":"2024-03-22","current":-44.715253,"twenty":-48.802819,"median":-47.994905,"eighty":-46.491065,"marketCap":672658887},{"date":"2024-03-28","current":-44.475279,"twenty":-48.79482,"median":-47.954909,"eighty":-44.667258,"marketCap":669048911},{"date":"2024-04-05","current":-20.510023,"twenty":-48.626838,"median":-47.554952,"eighty":-43.603371,"marketCap":660023970},{"date":"2024-04-12","current":-20.47263,"twenty":-48.442858,"median":-46.715041,"eighty":-20.502545,"marketCap":658820645},{"date":"2024-04-19","current":-19.182574,"twenty":-48.32287,"median":-44.795244,"eighty":-20.47263,"marketCap":617305919},{"date":"2024-04-26","current":-19.5752,"twenty":-48.106893,"median":-44.595266,"eighty":-20.42028,"marketCap":629940836},{"date":"2024-05-03","current":-19.593896,"twenty":-47.994905,"median":-43.535379,"eighty":-19.762164,"marketCap":630542499},{"date":"2024-05-10","current":-20.659595,"twenty":-47.994905,"median":-20.566113,"eighty":-19.777121,"marketCap":664837272},{"date":"2024-05-17","current":-26.212445,"twenty":-47.994905,"median":-20.911997,"eighty":-19.833211,"marketCap":843531091},{"date":"2024-05-24","current":-4.001469,"twenty":-47.970907,"median":-20.566113,"eighty":-19.605114,"marketCap":803821353},{"date":"2024-05-31","current":-4.492667,"twenty":-47.922913,"median":-20.510023,"eighty":-19.496675,"marketCap":902494035},{"date":"2024-06-07","current":-4.456726,"twenty":-47.746932,"median":-20.481978,"eighty":-19.242403,"marketCap":895274082},{"date":"2024-06-14","current":-4.444746,"twenty":-47.554952,"median":-20.47263,"eighty":-4.563951,"marketCap":892867431},{"date":"2024-06-21","current":-4.336922,"twenty":-47.554952,"median":-20.47263,"eighty":-4.498658,"marketCap":871207575},{"date":"2024-06-28","current":-4.375858,"twenty":-47.330976,"median":-20.453933,"eighty":-4.49087,"marketCap":879029190},{"date":"2024-07-05","current":-4.729281,"twenty":-46.939017,"median":-20.360451,"eighty":-4.493865,"marketCap":950025387},{"date":"2024-07-12","current":-4.666384,"twenty":-46.491065,"median":-20.080004,"eighty":-4.499856,"marketCap":937390471},{"date":"2024-07-15","current":-4.792179,"twenty":-46.267089,"median":-20.014567,"eighty":-4.501054,"marketCap":962660304},{"date":"2024-08-02","current":-4.753242,"twenty":-46.043112,"median":-19.949129,"eighty":-4.502252,"marketCap":954838689},{"date":"2024-08-09","current":-4.193156,"twenty":-45.163206,"median":-19.771513,"eighty":-4.476494,"marketCap":842327766},{"date":"2024-08-16","current":-2.818059,"twenty":-44.779246,"median":-19.612593,"eighty":-4.43576,"marketCap":969439268},{"date":"2024-08-23","current":-2.836909,"twenty":-44.643261,"median":-19.584548,"eighty":-4.379452,"marketCap":975923811},{"date":"2024-08-30","current":-3.106462,"twenty":-44.595266,"median":-19.425628,"eighty":-4.335724,"marketCap":1068652785},{"date":"2024-09-06","current":-4.073462,"twenty":-44.547271,"median":-19.332146,"eighty":-4.230058,"marketCap":1401309871},{"date":"2024-09-13","current":-3.988638,"twenty":-44.235304,"median":-7.878845,"eighty":-4.193156,"marketCap":1372129425},{"date":"2024-09-20","current":-5.33452,"twenty":-43.603371,"median":-4.857618,"eighty":-4.199566,"marketCap":1835125838},{"date":"2024-09-27","current":-5.343032,"twenty":-36.402227,"median":-4.781696,"eighty":-4.199566,"marketCap":1838054195},{"date":"2024-10-04","current":-5.755604,"twenty":-24.956043,"median":-4.880237,"eighty":-4.209959,"marketCap":1979982860},{"date":"2024-10-11","current":-4.598218,"twenty":-22.592809,"median":-4.868927,"eighty":-4.213365,"marketCap":1581830780},{"date":"2024-10-18","current":-4.725113,"twenty":-21.590679,"median":-4.792179,"eighty":-4.229539,"marketCap":1625484098},{"date":"2024-10-25","current":-4.888949,"twenty":-20.962478,"median":-4.790222,"eighty":-4.249285,"marketCap":1681845104},{"date":"2024-10-31","current":-4.998173,"twenty":-20.648377,"median":-4.810961,"eighty":-4.266836,"marketCap":1719419108},{"date":"2024-11-08","current":-5.61315,"twenty":-20.596027,"median":-4.880237,"eighty":-4.334526,"marketCap":1930977089},{"date":"2024-11-15","current":-3.401519,"twenty":-20.554895,"median":-4.900821,"eighty":-4.334526,"marketCap":2003855918},{"date":"2024-11-22","current":-3.557753,"twenty":-20.510023,"median":-4.857618,"eighty":-4.212246,"marketCap":2051078846},{"date":"2024-11-29","current":-3.628847,"twenty":-20.510023,"median":-4.805844,"eighty":-4.193156,"marketCap":2092064783},{"date":"2024-12-06","current":-2.944188,"twenty":-20.491327,"median":-4.779739,"eighty":-4.113047,"marketCap":1697352390},{"date":"2024-12-13","current":-3.083283,"twenty":-20.491327,"median":-4.753242,"eighty":-3.988638,"marketCap":1777542266},{"date":"2024-12-20","current":-3.440295,"twenty":-20.47263,"median":-4.727197,"eighty":-3.815772,"marketCap":1983362950},{"date":"2024-12-27","current":-3.676757,"twenty":-20.47263,"median":-4.697136,"eighty":-3.712613,"marketCap":2119685740},{"date":"2025-01-03","current":-3.597937,"twenty":-20.47263,"median":-4.668442,"eighty":-3.657593,"marketCap":2074244810},{"date":"2025-01-10","current":-3.51757,"twenty":-20.47263,"median":-4.649598,"eighty":-3.630083,"marketCap":2027912881},{"date":"2025-01-17","current":-3.811216,"twenty":-20.47263,"median":-4.615467,"eighty":-3.610301,"marketCap":2197202621},{"date":"2025-01-24","current":-4.367598,"twenty":-20.465151,"median":-4.609477,"eighty":-3.628847,"marketCap":2517962128},{"date":"2025-01-31","current":-3.859127,"twenty":-20.427758,"median":-4.5959,"eighty":-3.629465,"marketCap":2224823579},{"date":"2025-02-07","current":-3.491297,"twenty":-20.382887,"median":-4.55257,"eighty":-3.628847,"marketCap":2012765905},{"date":"2025-02-14","current":-4.733883,"twenty":-20.293145,"median":-4.531604,"eighty":-3.604119,"marketCap":2729128803},{"date":"2025-02-21","current":-4.54224,"twenty":-20.173487,"median":-4.551073,"eighty":-3.628847,"marketCap":2618644973},{"date":"2025-02-28","current":-4.291868,"twenty":-20.080004,"median":-4.534513,"eighty":-3.628847,"marketCap":2474303195},{"date":"2025-03-07","current":-3.568572,"twenty":-19.949129,"median":-4.506443,"eighty":-3.628847,"marketCap":2057315836},{"date":"2025-03-14","current":-3.656666,"twenty":-19.855647,"median":-4.498658,"eighty":-3.616483,"marketCap":2108102758},{"date":"2025-03-21","current":-3.688441,"twenty":-19.799557,"median":-4.493498,"eighty":-3.616483,"marketCap":2320276640},{"date":"2025-03-28","current":-3.714026,"twenty":-19.743468,"median":-4.48816,"eighty":-3.616483,"marketCap":2336371044},{"date":"2025-04-04","current":-3.081519,"twenty":-19.706075,"median":-4.44175,"eighty":-3.606002,"marketCap":1938481601},{"date":"2025-04-11","current":-2.477439,"twenty":-19.612593,"median":-4.43576,"eighty":-3.570468,"marketCap":1558474829},{"date":"2025-04-17","current":-2.787296,"twenty":-19.597635,"median":-4.41653,"eighty":-3.557444,"marketCap":1753395950},{"date":"2025-04-25","current":-2.787296,"twenty":-19.593896,"median":-4.401482,"eighty":-3.529934,"marketCap":1753395950},{"date":"2025-05-02","current":-2.841765,"twenty":-19.578939,"median":-4.381848,"eighty":-3.496243,"marketCap":1787660543},{"date":"2025-05-09","current":-2.978101,"twenty":-19.4705,"median":-4.366826,"eighty":-3.412757,"marketCap":1873425367},{"date":"2025-05-16","current":-4.5891,"twenty":-19.429367,"median":-4.367598,"eighty":-3.435349,"marketCap":2508938825},{"date":"2025-05-23","current":-5.794479,"twenty":-19.410671,"median":-4.383223,"eighty":-3.441532,"marketCap":3167939997},{"date":"2025-05-30","current":-4.998561,"twenty":-19.36206,"median":-4.401482,"eighty":-3.471515,"marketCap":2732798228},{"date":"2025-06-06","current":-4.217252,"twenty":-19.242403,"median":-4.399819,"eighty":-3.495006,"marketCap":2305643289},{"date":"2025-06-13","current":-4.171827,"twenty":-14.252336,"median":-4.392209,"eighty":-3.509534,"marketCap":2280808699},{"date":"2025-06-20","current":-4.088245,"twenty":-8.972656,"median":-4.378853,"eighty":-3.51757,"marketCap":2235113055},{"date":"2025-06-27","current":-4.050088,"twenty":-5.92305,"median":-4.367598,"eighty":-3.522516,"marketCap":2214251999},{"date":"2025-07-03","current":-4.22452,"twenty":-5.824946,"median":-4.351897,"eighty":-3.529934,"marketCap":2309616823},{"date":"2025-07-11","current":-3.961055,"twenty":-5.786704,"median":-4.335425,"eighty":-3.529934,"marketCap":2165576204},{"date":"2025-07-18","current":-5.149372,"twenty":-5.748008,"median":-4.320884,"eighty":-3.531789,"marketCap":2815249065},{"date":"2025-07-25","current":-5.207516,"twenty":-5.748008,"median":-4.342912,"eighty":-3.542607,"marketCap":2847037340},{"date":"2025-08-01","current":-5.572732,"twenty":-5.706632,"median":-4.366053,"eighty":-3.556517,"marketCap":3046707439},{"date":"2025-08-08","current":-5.274745,"twenty":-5.659883,"median":-4.371961,"eighty":-3.55868,"marketCap":2883792532},{"date":"2025-08-15","current":-5.817892,"twenty":-5.659883,"median":-4.384599,"eighty":-3.563626,"marketCap":2963325905},{"date":"2025-08-22","current":-5.313857,"twenty":-5.647035,"median":-4.404183,"eighty":-3.568951,"marketCap":2706597200},{"date":"2025-08-29","current":-5.477962,"twenty":-5.637377,"median":-4.41653,"eighty":-3.571634,"marketCap":2790183290},{"date":"2025-09-05","current":-4.489428,"twenty":-5.626437,"median":-4.43576,"eighty":-3.576299,"marketCap":2286676605},{"date":"2025-09-12","current":-4.522639,"twenty":-5.624483,"median":-4.43576,"eighty":-3.597937,"marketCap":2303592837},{"date":"2025-09-19","current":-4.700419,"twenty":-5.61315,"median":-4.43576,"eighty":-3.604581,"marketCap":2394144435},{"date":"2025-09-26","current":-3.936552,"twenty":-5.572732,"median":-4.437257,"eighty":-3.606002,"marketCap":2005071087},{"date":"2025-10-03","current":-3.821288,"twenty":-5.563921,"median":-4.426775,"eighty":-3.606002,"marketCap":1946361810},{"date":"2025-10-10","current":-3.838871,"twenty":-5.549318,"median":-4.409354,"eighty":-3.616483,"marketCap":1955317462},{"date":"2025-10-17","current":-2.563155,"twenty":-5.548292,"median":-4.399819,"eighty":-3.597937,"marketCap":1305535120},{"date":"2025-10-24","current":-2.738981,"twenty":-5.547051,"median":-4.381913,"eighty":-3.568572,"marketCap":1395091645},{"date":"2025-10-31","current":-2.5065,"twenty":-5.540478,"median":-4.368063,"eighty":-3.539207,"marketCap":1276678017},{"date":"2025-11-07","current":-0.945554,"twenty":-5.532419,"median":-4.358975,"eighty":-3.51757,"marketCap":481615090},{"date":"2025-11-14","current":-1.676313,"twenty":-5.527307,"median":-4.336922,"eighty":-3.455961,"marketCap":853824978},{"date":"2025-11-21","current":-1.695809,"twenty":-5.483699,"median":-4.317243,"eighty":-3.411027,"marketCap":617537250},{"date":"2025-11-28","current":-1.640078,"twenty":-5.482245,"median":-4.300534,"eighty":-3.376311,"marketCap":597242599},{"date":"2025-12-05","current":-2.030194,"twenty":-5.478746,"median":-4.251086,"eighty":-3.332419,"marketCap":739305159},{"date":"2025-12-12","current":-2.245155,"twenty":-5.477962,"median":-4.24482,"eighty":-3.219906,"marketCap":817584529},{"date":"2025-12-19","current":-3.284137,"twenty":-5.47383,"median":-4.22452,"eighty":-3.171377,"marketCap":1195934817},{"date":"2025-12-26","current":-3.925041,"twenty":-5.467025,"median":-4.216721,"eighty":-3.152831,"marketCap":1429323308},{"date":"2026-01-02","current":-3.590656,"twenty":-5.462381,"median":-4.209181,"eighty":-3.168286,"marketCap":1307555399},{"date":"2026-01-09","current":-3.71406,"twenty":-5.448387,"median":-4.203223,"eighty":-3.173483,"marketCap":1352493556},{"date":"2026-01-16","current":-4.609734,"twenty":-5.428691,"median":-4.209181,"eighty":-3.181181,"marketCap":1678657597},{"date":"2026-01-23","current":-4.936157,"twenty":-5.426739,"median":-4.211657,"eighty":-3.198578,"marketCap":1797526270},{"date":"2026-01-30","current":-3.980772,"twenty":-5.420626,"median":-4.203223,"eighty":-3.238143,"marketCap":1449617960},{"date":"2026-02-06","current":-2.917906,"twenty":-5.414621,"median":-4.193156,"eighty":-3.221758,"marketCap":1062569964},{"date":"2026-02-13","current":-3.280156,"twenty":-5.410172,"median":-4.184611,"eighty":-3.221758,"marketCap":1194485199},{"date":"2026-02-20","current":-3.554829,"twenty":-5.405568,"median":-4.172735,"eighty":-3.227015,"marketCap":1294508838},{"date":"2026-02-27","current":-3.148791,"twenty":-5.400288,"median":-4.164559,"eighty":-3.227015,"marketCap":1146647806},{"date":"2026-03-06","current":-4.972012,"twenty":-5.382234,"median":-4.145533,"eighty":-3.220444,"marketCap":2039330591},{"date":"2026-03-13","current":-6.264377,"twenty":-5.400288,"median":-4.164559,"eighty":-3.227015,"marketCap":2569409300},{"date":"2026-03-20","current":-6.15309,"twenty":-5.421921,"median":-4.179095,"eighty":-3.244329,"marketCap":2523763634},{"date":"2026-03-27","current":-6.433102,"twenty":-5.463177,"median":-4.187166,"eighty":-3.280156,"marketCap":2638614021},{"date":"2026-04-02","current":-5.277154,"twenty":-5.477962,"median":-4.193156,"eighty":-3.282154,"marketCap":2164488064},{"date":"2026-04-10","current":-4.674051,"twenty":-5.477962,"median":-4.210154,"eighty":-3.28384,"marketCap":1917117999},{"date":"2026-04-17","current":-5.158687,"twenty":-5.47383,"median":-4.216721,"eighty":-3.290506,"marketCap":2115897515},{"date":"2026-04-24","current":-5.119198,"twenty":-5.465101,"median":-4.22452,"eighty":-3.29567,"marketCap":2099700666},{"date":"2026-05-01","current":-5.151508,"twenty":-5.461584,"median":-4.247484,"eighty":-3.3114,"marketCap":2112952634},{"date":"2026-05-08","current":-3.796171,"twenty":-5.435588,"median":-4.249415,"eighty":-3.332419,"marketCap":1889141623},{"date":"2026-05-15","current":-4.265077,"twenty":-5.428193,"median":-4.248766,"eighty":-3.345401,"marketCap":2122490012},{"date":"2026-05-22","current":-4.519431,"twenty":-5.423126,"median":-4.258081,"eighty":-3.350038,"marketCap":2249067598},{"date":"2026-05-29","current":-4.556653,"twenty":-5.418036,"median":-4.265077,"eighty":-3.352043,"marketCap":2267591147},{"date":"2026-06-05","current":-4.199938,"twenty":-5.412972,"median":-4.251086,"eighty":-3.354661,"marketCap":2090073801},{"date":"2026-06-12","current":-3.635397,"twenty":-5.40787,"median":-4.248125,"eighty":-3.366619,"marketCap":1809133305},{"date":"2026-06-18","current":-3.179421,"twenty":-5.403456,"median":-4.232696,"eighty":-3.35158,"marketCap":1582219827},{"date":"2026-06-26","current":-2.354323,"twenty":-5.393066,"median":-4.217252,"eighty":-3.303981,"marketCap":1171614486},{"date":"2026-07-02","current":-1.364825,"twenty":-5.382177,"median":-4.211657,"eighty":-3.284907,"marketCap":679196804},{"date":"2026-07-10","current":-1.594795,"twenty":-5.380699,"median":-4.209212,"eighty":-3.230478,"marketCap":793640368},{"date":"2026-07-17","current":-1.594795,"twenty":-5.372119,"median":-4.197265,"eighty":-3.175342,"marketCap":793640368},{"date":"2026-07-24","current":-1.795108,"twenty":-5.35754,"median":-4.190161,"eighty":-3.151179,"marketCap":893324665},{"date":"2026-07-31","current":-1.725769,"twenty":-5.356634,"median":-4.184611,"eighty":-3.106462,"marketCap":858818562},{"date":"2026-08-07","current":-1.845186,"twenty":-5.343032,"median":-4.171827,"eighty":-3.083283,"marketCap":918245739},{"date":"2026-08-14","current":-1.782492,"twenty":-5.33452,"median":-4.158252,"eighty":-3.025387,"marketCap":773234375},{"date":"2026-08-21","current":-2.24249,"twenty":-5.313857,"median":-4.13367,"eighty":-2.944188,"marketCap":972778730}],"updateTime":1787466039250},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SOC\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2640715405","title":"Rezolute Announces Four Presentations at the Upcoming Annual Meeting of the Endocrine Society","url":"https://stock-news.laohu8.com/highlight/detail?id=2640715405","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640715405?lang=en_us&edition=fundamental","pubTime":"2026-06-04 19:30","pubTimestamp":1780572600,"startTime":"0","endTime":"0","summary":"REDWOOD CITY, Calif., June  04, 2026  (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage ultra-rare disease company focused on treating refractory hypoglycem","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/04/3306662/0/en/Rezolute-Announces-Four-Presentations-at-the-Upcoming-Annual-Meeting-of-the-Endocrine-Society.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4161","BK4213","ENDO","LU2125154778.USD","LU2360032135.SGD","SOC","LU0029874061.USD","LU2125154935.USD","HI","LU0128526141.USD","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640292282","title":"Jefferies Remains a Buy on Sable Offshore (SOC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640292282","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640292282?lang=en_us&edition=fundamental","pubTime":"2026-06-03 08:38","pubTimestamp":1780447108,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Lloyd Byrne from Jefferies reiterated a Buy rating on Sable Offshore, with a price target of $24.00. Byrne covers t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jefferies-remains-a-buy-on-sable-offshore-soc-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jefferies-remains-a-buy-on-sable-offshore-soc-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4213","SOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640216921","title":"Gerdes Energy Research downgrades Sable Offshore (SOC) to a Hold","url":"https://stock-news.laohu8.com/highlight/detail?id=2640216921","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640216921?lang=en_us&edition=fundamental","pubTime":"2026-06-03 07:39","pubTimestamp":1780443557,"startTime":"0","endTime":"0","summary":"In a report released yesterday, from Gerdes Energy Research downgraded Sable Offshore to a Hold, with a price target of $13.00. The company’s share...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/gerdes-energy-research-downgrades-sable-offshore-soc-to-a-hold-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/gerdes-energy-research-downgrades-sable-offshore-soc-to-a-hold-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640913560","title":"U.S. RESEARCH ROUNDUP-Edgewise Therapeutics, IBM, Rubrik","url":"https://stock-news.laohu8.com/highlight/detail?id=2640913560","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640913560?lang=en_us&edition=fundamental","pubTime":"2026-06-02 15:49","pubTimestamp":1780386551,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Edgewise Therapeutics, IBM, Rubrik June 2 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Edgewise","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nL4N42A0K5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORCL","RVMD","SAIC","GGLL","HPE","BWA","MLM","TTWO","ACRE","ORCS","MOBI","ORCX","ODTX","GH","GOOGL","GOOW","CZR","NAVN","CAG","LTH","GOOP","BXMT","ORCU","VMC","CHWY","U","ALGT","BTSG","GOOX","RBRK","FULC","TMHC","ARXS","MAC","EW","IBM","PRAX","GOU","CIEN","MANE","OCTV","XFOR","BRKR","GOOY","CPB","UNX","EWTX","GGLS","SOC","SAIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640999274","title":"Sable Offshore Corp : Gerdes Energy Research Cuts to Neutral From Buy; Cuts Target Price by $4 to $13","url":"https://stock-news.laohu8.com/highlight/detail?id=2640999274","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640999274?lang=en_us&edition=fundamental","pubTime":"2026-06-02 11:07","pubTimestamp":1780369664,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nFWN4290Y0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SOC","BK4213"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640696959","title":"Trump secretaries to visit Sable Offshore, Politico reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2640696959","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640696959?lang=en_us&edition=fundamental","pubTime":"2026-06-02 02:16","pubTimestamp":1780337801,"startTime":"0","endTime":"0","summary":"Secretaries Wright, Burgum and Duffy are set to visit the Sable Offshore (SOC) project this week as the White House ramps up its California oil pus...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/trump-secretaries-to-visit-sable-offshore-politico-reports-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/trump-secretaries-to-visit-sable-offshore-politico-reports-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","XLE","DBC","DUG","FTXN","VDE","BWET","USOI","DIG","USL","BK4570","DBO","OILU","OILT","BK4588","IXC","OIH","IEO","USO","WTIU","USE","OILK","PXJ","UCO","DRIP","SCO","UGA","XES","SOC","XOP","DBE","DRLL","PXE","BK4213","BNO","GUSH","ERX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640827966","title":"Sable Offshore price target lowered to $22 from $24 at Roth Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2640827966","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640827966?lang=en_us&edition=fundamental","pubTime":"2026-06-02 01:05","pubTimestamp":1780333546,"startTime":"0","endTime":"0","summary":"Roth Capital lowered the firm’s price target on Sable Offshore (SOC) to $22 from $24 and keeps a Buy rating on the shares following the company’s n...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sable-offshore-price-target-lowered-to-22-from-24-at-roth-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sable-offshore-price-target-lowered-to-22-from-24-at-roth-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SOC","BK4213"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640668289","title":"Sable Offshore says Platform Hondo expected to come online in Q3","url":"https://stock-news.laohu8.com/highlight/detail?id=2640668289","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640668289?lang=en_us&edition=fundamental","pubTime":"2026-06-02 01:04","pubTimestamp":1780333496,"startTime":"0","endTime":"0","summary":"Sable Offshore (SOC) says Platforms Harmony and Heritage began flowing in May 2025 and April 2026, respectively, with Platform Hondo expected to co...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sable-offshore-says-platform-hondo-expected-to-come-online-in-q3-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sable-offshore-says-platform-hondo-expected-to-come-online-in-q3-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SOC","BK4213"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640353809","title":"UCB and Biogen Announce Publication in The Lancet of Positive Dapirolizumab Pegol (DZP) Phase 3 Study Results in Systemic Lupus Erythematosus","url":"https://stock-news.laohu8.com/highlight/detail?id=2640353809","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640353809?lang=en_us&edition=fundamental","pubTime":"2026-06-01 13:30","pubTimestamp":1780291800,"startTime":"0","endTime":"0","summary":"Publication adds to previously reported findings from Phase 3 PHOENYCS GO study, demonstrating statistically significant improvement in disease activity at Week 48 with dapirolizumab pegol plus standa","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/01/3304009/0/en/UCB-and-Biogen-Announce-Publication-in-The-Lancet-of-Positive-Dapirolizumab-Pegol-DZP-Phase-3-Study-Results-in-Systemic-Lupus-Erythematosus.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4211","BK4077","LU1066051811.HKD","BK4533","LU1935042215.USD","LU1935043023.USD","LU1935042991.SGD","BK4585","LU1066053197.SGD","LU0786609619.USD","BK4213","BK4214","LU2083900584.USD","IE00BMG7P694.USD","LU0889565916.HKD","PEG","LU0053666078.USD","IE00BMG7P587.USD","IE00B894F039.SGD","LU2346227817.USD","IE00BD4GTV84.USD","UCB","BK4523","APC","LU0109394709.USD","LU1674673691.USD","LU2417539215.USD","IE00B19Z9P08.USD","LU0314104364.USD","LU2237443978.SGD","IFN","LU1718418525.SGD","LU0882574139.USD","LU1366333091.USD","IE00BMG7P926.USD","BK4532","BIIB","SOC","LU2236285917.USD","LU1935043536.SGD","LU0149725797.USD","LU2237443549.SGD","IE00B19Z9Z06.USD","BK4588","IE00BD4GTW91.USD","LU0320765992.SGD","LU1366192091.USD","LU0170899867.USD","SLE","LU0157215616.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639114896","title":"District court denies California parks department bid to block Sable Offshore pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2639114896","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639114896?lang=en_us&edition=fundamental","pubTime":"2026-05-29 05:41","pubTimestamp":1780004516,"startTime":"0","endTime":"0","summary":"NEW YORK, May 28  - A U.S. District Court on Thursday denied the California Department of Parks and Recreation's bid to stop oil producer Sable Offshore Corp SOC.N from moving oil on a long-disputed pipeline linked to the Santa Ynez offshore platform.The denial marks a setback for California's efforts to stop the Santa Ynez project, which Sable restarted in March after intervention from the federal government. For Sable, it marks a major win and sent the company's shares up nearly 12%.* The Department of Parks and Recreation had sought preliminary injunctive relief, citing irreparable harm to it from the use of a section of Sable's pipeline under the Gaviota State Park.* The U.S. District Court for the Central District of California said the department \"manifestly failed to demonstrate that it will suffer irreparable harm in the absence of preliminary injunctive relief.\"* Parks and Recreation and the California governor's office did not immediately respond to requests for comment.* Sev","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nL1N42519Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SOC","BK4213"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638698439","title":"Systemic immune activation with eftilagimod alfa associated with statistically significant increased overall survival in late-stage cancer patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2638698439","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638698439?lang=en_us&edition=fundamental","pubTime":"2026-05-28 20:00","pubTimestamp":1779969600,"startTime":"0","endTime":"0","summary":"SYDNEY, AUSTRALIA, May  28, 2026  (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company targeting cancer and autoimmune dise","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/28/3302799/0/en/Systemic-immune-activation-with-eftilagimod-alfa-associated-with-statistically-significant-increased-overall-survival-in-late-stage-cancer-patients.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","LU1066053197.SGD","LU0077335932.USD","LU2265009873.SGD","BK4214","LU1935043536.SGD","LU1066051811.HKD","LU1674673691.USD","LU2237443622.USD","LU2237443978.SGD","LU2236285917.USD","LU1066051225.USD","LU1718418525.SGD","LU1935042488.USD","LU0314104364.USD","LU0053666078.USD","LU1935043023.USD","LU1804176565.USD","LU0157215616.USD","LU2420271590.USD","LU0149725797.USD","LU1778281490.HKD","BK4139","LU0882574139.USD","SOC","LU1366333091.USD","BK4213","LU0170899867.USD","LU1674673428.USD","LU1935042215.USD","LU1496350171.SGD","APC","LU2083900584.USD","LU2417539215.USD","LU2456880835.USD","ALC","BK4198","LU2237443549.SGD","LU1366192091.USD","LU1935042991.SGD","LU2237443382.USD","LU1066051498.USD","IMMP","LU0786609619.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638549517","title":"Sable Offshore Corp put volume heavy and directionally bearish","url":"https://stock-news.laohu8.com/highlight/detail?id=2638549517","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638549517?lang=en_us&edition=fundamental","pubTime":"2026-05-27 00:09","pubTimestamp":1779811767,"startTime":"0","endTime":"0","summary":"Bearish flow noted in Sable Offshore (SOC) Corp with 1,226 puts trading, or 3x expected. Most active are Jan-27 50 calls and 5/29 weekly 13 puts, w...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sable-offshore-corp-put-volume-heavy-and-directionally-bearish-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sable-offshore-corp-put-volume-heavy-and-directionally-bearish-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SOC","BK4213"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637575363","title":"Genmab to Highlight Advances Across Its Oncology Portfolio at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and the European Hematology Association (EHA) 2026 Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2637575363","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637575363?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:00","pubTimestamp":1779397200,"startTime":"0","endTime":"0","summary":"Media ReleaseCOPENHAGEN, Denmark; May 21, 2026  Twenty-three abstracts will highlight the versatility and strength of Genmab’s portfolio and pipeline, including data from the comprehensive epcoritamab","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/21/3299787/0/en/Genmab-to-Highlight-Advances-Across-Its-Oncology-Portfolio-at-the-2026-American-Society-of-Clinical-Oncology-ASCO-Annual-Meeting-and-the-European-Hematology-Association-EHA-2026-Co.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SOC","BK4117","BK4107","LU0266512127.USD","EPV","CRC","BK4213","AFG","LU0456854461.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635889728","title":"How Investors Are Reacting To Sable Offshore (SOC) Deeper Losses And High‑Risk Offshore Restart Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2635889728","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635889728?lang=en_us&edition=fundamental","pubTime":"2026-05-15 02:47","pubTimestamp":1778784462,"startTime":"0","endTime":"0","summary":"Sable Offshore Corp. has reported first-quarter 2026 results, generating US$1.27 million in revenue while recording a net loss of US$197.03 million and a basic loss per share from continuing operations of US$1.37, and it continues to advance refinancing discussions on its Senior Secured Term Loan.\nAlongside these weak financials, the company is restarting production at its Santa Ynez assets and preparing Platform Hondo to begin operations, highlighting a high‑spend, high‑risk push to turn...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/7131000-choice2-main-header/1585186813996","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/7131000-choice2-main-header/1585186813996"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/energy/nyse-soc/sable-offshore/news/how-investors-are-reacting-to-sable-offshore-soc-deeper-loss","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/energy/nyse-soc/sable-offshore/news/how-investors-are-reacting-to-sable-offshore-soc-deeper-loss","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SOC","SOC.AU","BK4213","ISBC","BK4211","BK7061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635717053","title":"GRI Bio Reports First Quarter 2026 Financial Results, New Data Reinforcing Differentiated Profile of GRI-0621 in Idiopathic Pulmonary Fibrosis and Highlights Continued Advancement of Differentiated Immune-Modulating Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2635717053","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635717053?lang=en_us&edition=fundamental","pubTime":"2026-05-14 20:35","pubTimestamp":1778762100,"startTime":"0","endTime":"0","summary":"Phase 2a data show zero cough and 60% lower treatment-related diarrhea than placebo despite higher nintedanib use in the active arm – suggesting GRI-0621 may mitigate nintedanib-related GI-toxicities ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/14/3294952/0/en/GRI-Bio-Reports-First-Quarter-2026-Financial-Results-New-Data-Reinforcing-Differentiated-Profile-of-GRI-0621-in-Idiopathic-Pulmonary-Fibrosis-and-Highlights-Continued-Advancement-o.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4213","SOC","GRI","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635654627","title":"MEDIPOST's CARTISTEM® Meets All Primary and Secondary Endpoints in Japan Phase 3 Trial and Demonstrates Statistically Significant Efficacy Gains Versus Active Control","url":"https://stock-news.laohu8.com/highlight/detail?id=2635654627","media":"prnewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635654627?lang=en_us&edition=fundamental","pubTime":"2026-05-14 10:30","pubTimestamp":1778725800,"startTime":"0","endTime":"0","summary":"- Achieved statistical significance versus standard-of-care  control across all key efficacy endpoints in the 52-week study- Japan Phase 3 results strengthen CARTISTEM's global commercial prospects, with Japan biologics license application  scheduled for 2H 2026 SEOUL, South Korea and TOKYO, May 14, 2026 /PRNewswire/ -- MEDIPOST has met all primary and secondary efficacy endpoints in the Japan Phase 3 clinical trial of CARTISTEM, demonstrating clinical improvements in pain and function as well as cartilage regeneration. Based on the results, MEDIPOST is expected to accelerate preparations for its biologics license application  filing in Japan later this year.MEDIPOST CARTISTEM Japan Phase 3 Results Press Conference – Antonio Lee, Executive Vice President of Global Business Division at MEDIPOST","market":"other","thumbnail":"https://mma.prnewswire.com/media/2979923/final.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2979923/final.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/mediposts-cartistem-meets-all-primary-and-secondary-endpoints-in-japan-phase-3-trial-and-demonstrates-statistically-significant-efficacy-gains-versus-active-control-302771733.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SOC","BLA.AU","VAS.AU","SOC.AU","BK4213","BK7061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634218216","title":"Press Release: Sionna Therapeutics Reports First Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2634218216","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634218216?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:00","pubTimestamp":1778583600,"startTime":"0","endTime":"0","summary":"Enrollment completed in the PreciSION CF Phase 2a proof-of-concept trial evaluating NBD1 stabilizer SION-719 as an add-on to standard of care in participants with cystic fibrosis; topline data on track for the summer of 2026. Ongoing Phase 1 trial evaluating NBD1 stabilizer SION-451 in proprietary dual combinations with SION-2222 and with SION-109 in healthy volunteers is also on track for topline data in the summer of 2026. Maintained strong cash position with approximately $289.9 million in cash and cash equivalents, expected to fund operations into 2028. \"We entered 2026 with strong execution across our programs, highlighted by the recent completion of enrollment in our proof-of-concept Phase 2a trial of SION-719, an important milestone for Sionna,\" said Mike Cloonan, President and Chief Executive Officer of Sionna. \"With both of our clinical stage NBD1 stabilizer programs on track for topline readouts this summer, we remain focused on advancing these first-in-class product candidat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","SOC","BK4093","BK4181","SION","BK4218","CF","PK","BK4139","BK4213","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633489704","title":"Emerging Growth Status at Sable Offshore Corp. Raises Transparency and Valuation Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=2633489704","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633489704?lang=en_us&edition=fundamental","pubTime":"2026-05-08 14:01","pubTimestamp":1778220107,"startTime":"0","endTime":"0","summary":"Sable Offshore Corp. (SOC) has disclosed a new risk, in the Share Price & Shareholder Rights category. Sable Offshore Corp. is classified as an eme...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/emerging-growth-status-at-sable-offshore-corp-raises-transparency-and-valuation-concerns?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/emerging-growth-status-at-sable-offshore-corp-raises-transparency-and-valuation-concerns?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4213","SOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633174191","title":"Press Release: IN8bio Reports First Quarter 2026 Financial Results and Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2633174191","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633174191?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:30","pubTimestamp":1778185800,"startTime":"0","endTime":"0","summary":"-- Advancing next-generation <GAMMA> T cell engager platform with initial. -- Reported glioblastoma  data showing 97% improvement in. \"In the first quarter of 2026, we continued to advance our next-generation TCE platform and clinical programs,\" said William Ho, Chief Executive Officer and co-founder of IN8bio. \"Our encouraging GBM data positions us to engage the FDA on potential regulatory pathways forward, and we expect to deliver meaningful preclinical, regulatory and clinical milestones across our pipeline this year. As industry interest in novel TCEs accelerates, our next-generation platform is designed to address the key challenges in TCE development. We believe IN8bio is well positioned to create meaningful value for patients and shareholders in 2026 and beyond. We look forward to sharing further updates across our programs at our upcoming R&D Day in New York City on May 21, 2026.\". -- Median progression-free survival  for repeat dose patients was 13.0","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4187","BK4209","LU0154245756.USD","BK4213","BK4504","BK4585","BK4139","LU0963586101.USD","DRI","BK4006","IE00B66KJ199.SGD","BK4588","INAB","CRS","IE00B7SZL793.SGD","IE0031619046.USD","BK4196","IE00B19Z4B17.USD","SBC","LU0154245673.USD","SOC","LU2065731478.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633127581","title":"Sable Offshore (SOC) Receives a Rating Update from a Top Analyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2633127581","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633127581?lang=en_us&edition=fundamental","pubTime":"2026-05-08 01:15","pubTimestamp":1778174138,"startTime":"0","endTime":"0","summary":"In a report released today, Leo Mariani from Roth MKM maintained a Buy rating on Sable Offshore, with a price target of $24.00. According to TipRan...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/sable-offshore-soc-receives-a-rating-update-from-a-top-analyst-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/sable-offshore-soc-receives-a-rating-update-from-a-top-analyst-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SOC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}